Table 1 Distribution of clinical and laboratory parameters by acute cholecystitis stages
From: The role of serum and urıne neopterın levels on the determınatıon of acute cholecystıtıs severıty
Stage 1(n = 37) | Stage 2 (n = 18) | Stage 3 (n = 8) | Total (n = 63) | p | |
|---|---|---|---|---|---|
Age (years) Mean ± SD Median [min–max] | 49.05 ± 14.48 48 [21–80] | 57.94 ± 12.04 58 [35–76] | 59.62 ± 13.73 61 [33–77] | 52.93 ± 14.31 55 [21–80] | |
Gender, n (%) Male Female | 20 (54.1) 17 (45.9) | 14 (77.7) 4 (22.3) | 4 (50) 4 (50) | ||
WBC, (/mL) | 11,607 (± 2446) | 16,917 (± 3323) | 23,738(± 18,110) | 14,665.23 | < 0.01* |
CRP, (mg/L) | 71.44 (± 68.14) | 233.08 (± 110.87) | 195.03(± 131.01) | 133.32 | < 0.01* |
Procalcitonin (ng/mL) | 0.12 (± 0.13) | 0.86 (± 0.84) | 7.41(± 15.68) | 1.26 | 0.04* |
S-NEO*, (nmol/L) | 15.78 ± 5.05* | 28.91 ± 10.52 | 40.92 ± 7.82 | 22.72 ± 11.61 | < 0.01** |
U-NEO*, (µmol/L) | 3.06 ± 2.56 | 4.28 ± 3.57 | 4.40 ± 2.42 | 3.58 ± 2.89 | 0.239* |